BRZE Braze | $44.30 -12.4% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | N/A | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CLRB Cellectar Biosciences | $3.98 +9.6% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | N/A | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024 |
POOL Pool | $403.50 -2.7% | 3/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $407.00 -> $436.00 | N/A | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024 |
RUM Rumble | $8.08 -4.9% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024 |
SPXC SPX Technologies | $123.13 +1.4% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $134.00 | N/A | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024 |
CXM Sprinklr | $12.27 -5.7% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
|
VRNT Verint Systems | $33.15 +6.6% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024 |
IMVT Immunovant | $32.31 -0.6% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | N/A | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024 |
XERS Xeris Biopharma | $2.21 +8.3% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $5.00 | N/A | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024 |
CPRX Catalyst Pharmaceuticals | $15.94 -2.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024 |
CGTX Cognition Therapeutics | $1.82
| 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024 |
FRGE Forge Global | $1.93 -7.2% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $3.50 | Low | View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024 |
PRGS Progress Software | $53.31 +1.3% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $66.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
STRO Sutro Biopharma | $5.65 +14.6% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024 |
WPRT Westport Fuel Systems | $6.74 -0.9% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
ADBE Adobe | $504.60 +0.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024 |
UPS United Parcel Service | $148.63 +0.9% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $153.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024 |
HCI HCI Group | $116.08 +0.5% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024 |
VKTX Viking Therapeutics | $82.00 -1.6% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $138.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
ALSN Allison Transmission | $81.16 +0.4% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024 |
A Agilent Technologies | $145.51 -1.3% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024 |
HARP Harpoon Therapeutics | $23.01 +0.1% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | N/A | View details for Oppenheimer rating of Harpoon Therapeutics (NASDAQ:HARP) on 3/26/2024 |
ADUS Addus HomeCare | $103.34 -0.4% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024 |
DYN Dyne Therapeutics | $28.39 -0.4% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024 |
TH Target Hospitality | $10.87 -0.8% | 3/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024 |
TSLA Tesla | $175.79 -2.2% | 3/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024 |
AMPX Amprius Technologies | $2.65 +0.4% | 3/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024 |
DRI Darden Restaurants | $167.15 +0.1% | 3/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $186.00 -> $182.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
FDS FactSet Research Systems | $454.39 +1.6% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024 |
FDX FedEx | $289.74 +0.6% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024 |
SHAK Shake Shack | $104.03 -0.2% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $120.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024 |
ROP Roper Technologies | $560.84 +0.3% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024 |
KNF Knife River | $81.08 +1.3% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024 |
DMAC DiaMedica Therapeutics | $2.77 +4.5% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024 |
TKR Timken | $87.43 -0.8% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $100.00 | Low | View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024 |
TOL Toll Brothers | $129.37 +1.5% | 3/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $141.00 -> $157.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024 |
TRVI Trevi Therapeutics | $3.45 -0.6% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024 |
VOR Vor Biopharma | $2.37 +7.2% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
DKS DICK'S Sporting Goods | $224.86 +1.0% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $240.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024 |
CSL Carlisle Companies | $391.85 +0.8% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $405.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024 |
[BUY ALERT] Our #1 A.I. Stock for March (Ad) It's the one AI stock nobody is talking about.
Cathy Wood just bought 11 million shares of it. Get the name of the stock here - before it takes off >>> |
CRNX Crinetics Pharmaceuticals | $46.81 +5.4% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
EQIX Equinix | $825.33 +1.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $875.00 -> $950.00 | Low | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024 |
NVDA NVIDIA | $903.56 +0.1% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024 |
CRVS Corvus Pharmaceuticals | $1.78 -0.6% | 3/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024 |
STEP StepStone Group | $35.74 +1.8% | 3/20/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024 |
GRWG GrowGeneration | $2.86 -6.2% | 3/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024 |
C Citigroup | $63.24 +0.8% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $88.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024 |
CATX Perspective Therapeutics | 1.19 -0.8% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024 |
GS The Goldman Sachs Group | $417.69 +0.6% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $506.00 -> $446.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024 |
JPM JPMorgan Chase & Co. | $200.30 +0.4% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $238.00 -> $219.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024 |
MS Morgan Stanley | $94.16 +0.7% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $109.00 -> $97.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024 |
USB U.S. Bancorp | $44.70 +1.6% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $55.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024 |
WFC Wells Fargo & Company | $57.96 +0.6% | 3/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024 |
ALPN Alpine Immune Sciences | $39.64 +2.6% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $44.00 | Low | View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
BAC Bank of America | $37.92 +0.3% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024 |
MOD Modine Manufacturing | $95.19 -0.1% | 3/19/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024 |
CRBP Corbus Pharmaceuticals | $39.24 +10.3% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $46.81 +5.4% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $167.15 +0.1% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $180.10 +1.0% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $64.36 +1.7% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
ADBE Adobe | $504.60 +0.0% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
LEN Lennar | $171.98 +2.1% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $267.04 +3.2% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $18.98 +1.5% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $71.90 -0.2% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
SMAR Smartsheet | $38.50 +0.3% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $15.00 +0.3% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $317.53 +1.1% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $95.56 +0.4% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $172.01 +0.2% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $5.50 -5.2% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $607.33 -1.0% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $12.12
| 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $4.98 +0.2% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $44.22 +0.7% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $11.65 +0.8% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $9.04 +2.1% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $85.44 +0.5% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $6.51 +0.8% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $171.28 +0.3% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $10.74 -2.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $22.24 -0.9% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.90
| 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $26.31 +0.7% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $320.59 -0.5% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $156.06 +1.2% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $26.95 -0.2% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $43.35 -2.9% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad) You might have seen that Bitcoin was one of the best performing assets of 2023.
It gained 164%.
But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin.
He found something better. Click here to find out that this 8,788% cryptocurrency is. |
MCRB Seres Therapeutics | $0.77 -0.8% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
SCM Stellus Capital Investment | $13.08 -0.5% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $14.00 | Low | View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024 |
SYF Synchrony Financial | $43.12 +2.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024 |
AEVA Aeva Technologies | $3.93 +11.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024 |
ETNB 89bio | $11.64 +2.9% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024 |
CODI Compass Diversified | $24.07 +0.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024 |
COST Costco Wholesale | $732.63 +0.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $760.00 -> $805.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024 |
DYN Dyne Therapeutics | $28.39 -0.4% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024 |
GE General Electric | $175.53 -2.5% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024 |
IMRX Immuneering | $2.89 +18.9% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024 |
GWW W.W. Grainger | $1,017.30 -0.3% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,075.00 -> $1,125.00 | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $16.89 +0.3% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $29.00 | Low | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
DLTR Dollar Tree | $133.15 +0.5% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024 |
CYTK Cytokinetics | $70.11 -1.8% | 3/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $107.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024 |
LOW Lowe's Companies | $254.73 +0.6% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $230.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024 |
MDGL Madrigal Pharmaceuticals | $267.04 +3.2% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024 |
SG Sweetgreen | $25.26 -0.9% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $17.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024 |
PNTG The Pennant Group | $19.63 -1.1% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $22.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024 |
ADSK Autodesk | $260.42 -0.2% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $265.00 -> $315.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024 |
AVGO Broadcom | $1,325.41 +0.5% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,500.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024 |
ESTC Elastic | $100.24 +0.1% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024 |
HRZN Horizon Technology Finance | $11.37 +1.2% | 3/1/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024 |
EVH Evolent Health | $32.79 +0.2% | 3/1/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024 |
TBLA Taboola.com | $4.44 +0.9% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024 |
CHE Chemed | $641.93 -0.4% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $650.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024 |
CRNX Crinetics Pharmaceuticals | $46.81 +5.4% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $48.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024 |
IMCR Immunocore | $65.00 +2.2% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024 |
MRVL Marvell Technology | $70.88 -2.0% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024 |
MMSI Merit Medical Systems | $75.75 +0.4% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $87.00 | Low | View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024 |
OKTA Okta | $104.62 -0.3% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $125.00 | Low | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024 |
RLJ RLJ Lodging Trust | $11.82 +0.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 2/29/2024 |
RXST RxSight | $51.58 +1.8% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $61.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.18 -4.9% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $42.00 -> $17.00 | Low | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SNOW Snowflake | $161.60 +1.0% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $220.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
ARVN Arvinas | $41.28 -0.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
CLVT Clarivate | $7.43 -0.4% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 2/28/2024 |
COMP Compass | $3.60 +3.7% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/28/2024 |
FSLR First Solar | $168.80 +0.8% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $268.00 -> $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 2/28/2024 |
IAS Integral Ad Science | $9.97 +6.1% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $20.00 | Low | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2024 |
QUIK QuickLogic | $16.03 +2.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $16.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 2/28/2024 |
RSG Republic Services | $191.44 0.0% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $182.00 -> $195.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 2/28/2024 |
TARS Tarsus Pharmaceuticals | $36.35 +5.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $59.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024 |
VKTX Viking Therapeutics | $82.00 -1.6% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $116.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 2/28/2024 |
WMT Walmart | $60.17 -0.9% | 2/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $67.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/26/2024 |
CARG CarGurus | $23.08 +0.3% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/27/2024 |
DAWN Day One Biopharmaceuticals | $16.52 +4.6% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/27/2024 |
FATE Fate Therapeutics | $7.34
| 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
TMDX TransMedics Group | $73.94 -0.2% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $105.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
IONS Ionis Pharmaceuticals | $43.35 -2.9% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform | $63.00 -> $65.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/26/2024 |
MAIN Main Street Capital | $47.31 +1.1% | 2/26/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $41.00 -> $43.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 2/26/2024 |
[BUY ALERT] Our #1 A.I. Stock for March (Ad) It's the one AI stock nobody is talking about.
Cathy Wood just bought 11 million shares of it. Get the name of the stock here - before it takes off >>> |
POOL Pool | $403.50 -2.7% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $407.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 2/26/2024 |
SONY Sony Group | $85.74 -0.9% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $108.00 | Low | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/26/2024 |
TGT Target | $177.21 +1.5% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $170.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 2/26/2024 |
NICE NICE | $260.62 +2.0% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $225.00 -> $300.00 | Low | View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 2/23/2024 |
OLED Universal Display | $168.45 +0.4% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $200.00 | Low | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 2/23/2024 |
SPXC SPX Technologies | $123.13 +1.4% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $124.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/23/2024 |
TOL Toll Brothers | $129.37 +1.5% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $141.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/23/2024 |
ACA Arcosa | $85.86 -0.2% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $90.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 2/23/2024 |
ALTR Altair Engineering | $86.15 -0.1% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Altair Engineering (NASDAQ:ALTR) on 2/23/2024 |
BLDR Builders FirstSource | $208.55 -0.5% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $242.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 2/23/2024 |
CCAP Crescent Capital BDC | $17.26 +1.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $19.00 | Low | View details for Oppenheimer rating of Crescent Capital BDC (NASDAQ:CCAP) on 2/23/2024 |
INTU Intuit | $650.00 +0.2% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $678.00 -> $712.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 2/23/2024 |
CYH Community Health Systems | $3.50 +2.9% | 2/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.50 -> $5.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 2/22/2024 |
DOCN DigitalOcean | $38.18 -2.3% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $46.00 | Low | View details for Oppenheimer rating of DigitalOcean (NASDAQ:DOCN) on 2/22/2024 |
NVDA NVIDIA | $903.56 +0.1% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ADI Analog Devices | $197.79 +2.3% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $215.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/22/2024 |
JACK Jack in the Box | $68.48 -2.8% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $98.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
PNST Pinstripes | $3.25 -1.8% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 2/22/2024 |
CAKE Cheesecake Factory | $36.15 -0.6% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
RUN Sunrun | $13.18 +0.6% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 2/22/2024 |
CNNE Cannae | $22.24 -0.9% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 2/22/2024 |
ADSK Autodesk | $260.42 -0.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $265.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 2/22/2024 |
GWRE Guidewire Software | $116.71 +1.1% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $130.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 2/22/2024 |
VEEV Veeva Systems | $231.69 -0.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $225.00 | Low | View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 2/22/2024 |
SKIL Skillsoft | $9.00 +0.8% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 2/22/2024 |
CLH Clean Harbors | $201.31 +0.4% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $178.00 -> $200.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/22/2024 |
DPZ Domino's Pizza | $496.88 +1.0% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $470.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 2/22/2024 |
NVRO Nevro | $14.44 +0.1% | 2/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Nevro (NYSE:NVRO) on 2/22/2024 |
VTYX Ventyx Biosciences | $5.50 -5.2% | 2/21/2024 | Reiterated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/21/2024 |
LYV Live Nation Entertainment | $105.77 -1.0% | 2/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $115.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 2/21/2024 |
MDT Medtronic | $87.15 +0.3% | 2/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $89.00 -> $92.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 2/21/2024 |
PANW Palo Alto Networks | $284.13 +0.7% | 2/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $310.00 -> $305.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
TPH Tri Pointe Homes | $38.66 +1.9% | 2/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $41.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/21/2024 |
B Barnes Group | $37.15 -0.9% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $43.00 | Low | View details for Oppenheimer rating of Barnes Group (NYSE:B) on 2/20/2024 |
DKNG DraftKings | $45.41 +0.1% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/20/2024 |
PRTA Prothena | $24.77 -1.6% | 2/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $80.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/20/2024 |
ALB Albemarle | $131.74 +2.3% | 2/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $191.00 -> $188.00 | Low | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 2/16/2024 |
BLZE Backblaze | $10.23 +0.7% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.50 -> $11.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 2/16/2024 |
COIN Coinbase Global | $265.12 +3.3% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $137.72 -0.8% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $140.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
FRPT Freshpet | $115.86 +0.1% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $115.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 2/16/2024 |
NVDA NVIDIA | $903.56 +0.1% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
SCI Service Co. International | $74.21 0.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $76.00 | Low | View details for Oppenheimer rating of Service Co. International (NYSE:SCI) on 2/16/2024 |
SHAK Shake Shack | $104.03 -0.2% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $108.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 2/16/2024 |
TTD Trade Desk | $87.42 +0.2% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $105.00 | Low | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 2/16/2024 |
ROKU Roku | $65.17 -0.6% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
NKE NIKE | $93.98 -0.2% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $110.00 | Low | View details for Oppenheimer rating of NIKE (NYSE:NKE) on 2/16/2024 |
BIIB Biogen | $215.63 -0.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $290.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 2/14/2024 |
BOWL Bowlero | $13.70 +1.0% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $18.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 2/14/2024 |
DENN Denny's | $8.96 -1.1% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
Top Project Outperforms BTC in 2023… (Ad) According to a recently published report…
One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen.
And now, this crypto coin is set to soar in the parabolic bull run projected in 2024. Just click here for instant access to the #1 Coin for 2024. |
GCMG GCM Grosvenor | $9.66 +4.0% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 2/14/2024 |
MCO Moody's | $393.03 +0.7% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $427.00 -> $411.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 2/14/2024 |
WCC WESCO International | $171.28 +0.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $175.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 2/14/2024 |
WM Waste Management | $213.15 -0.4% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $188.00 -> $212.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 2/14/2024 |
XPO XPO | $122.03 +0.9% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $130.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 2/14/2024 |
ANET Arista Networks | $289.98 +0.5% | 2/13/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Arista Networks (NYSE:ANET) on 2/13/2024 |
MNDY monday.com | $225.87 -0.4% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $240.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 2/13/2024 |
RXO RXO | $21.87 +2.9% | 2/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $22.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 2/13/2024 |
TRMB Trimble | $64.36 +1.7% | 2/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 2/13/2024 |
DKNG DraftKings | $45.41 +0.1% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $55.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/13/2024 |
GILD Gilead Sciences | $73.25 +0.3% | 2/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 2/12/2024 |
CRM Salesforce | $301.18 -0.1% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $325.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 2/12/2024 |
WMT Walmart | $60.17 -0.9% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.33 -> $61.67 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/12/2024 |
PSBD Palmer Square Capital BDC | $16.29 -1.0% | 2/12/2024 | Initiated by | Oppenheimer | - | Outperform | $17.00 | Low | View details for Oppenheimer rating of Palmer Square Capital BDC (NYSE:PSBD) on 2/12/2024 |
BILL BILL | $68.72 +1.6% | 2/9/2024 | Target Raised by | Oppenheimer | - | Overweight -> Overweight | $75.00 -> $83.00 | Low | View details for Oppenheimer rating of BILL (NYSE:BILL) on 2/9/2024 |
ENS EnerSys | $94.46 +0.3% | 2/9/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of EnerSys (NYSE:ENS) on 2/9/2024 |
FUN Cedar Fair | $41.90 +1.0% | 2/8/2024 | Initiated by | Oppenheimer | - | Outperform | $49.00 | Low | View details for Oppenheimer rating of Cedar Fair (NYSE:FUN) on 2/8/2024 |
ENPH Enphase Energy | $120.98 +1.0% | 2/7/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $133.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 2/7/2024 |
CHD Church & Dwight | $104.31 +0.1% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $110.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 2/5/2024 |
EXPE Expedia Group | $137.75 -0.9% | 2/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 2/5/2024 |
WT WisdomTree | $9.19 +2.9% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 2/5/2024 |
ACAD ACADIA Pharmaceuticals | $18.49 +1.6% | 2/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/5/2024 |
BKNG Booking | $3,627.88 -1.2% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $3,450.00 -> $4,200.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 2/5/2024 |
AAPL Apple | $171.48 -1.1% | 2/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 | Low | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 2/2/2024 |
CTVA Corteva | $57.67 +1.2% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $62.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 2/2/2024 |
COST Costco Wholesale | $732.63 +0.1% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $695.00 -> $760.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 2/2/2024 |
DOV Dover | $177.19 0.0% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $177.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 2/2/2024 |
THG The Hanover Insurance Group | $136.17 +0.5% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 2/2/2024 |
MPWR Monolithic Power Systems | $677.42 +0.6% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $700.00 | Low | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 2/2/2024 |
ENSG The Ensign Group | $124.42 -1.0% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $127.00 -> $130.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 2/2/2024 |
META Meta Platforms | $485.58 -1.7% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $385.00 -> $525.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
AMZN Amazon.com | $180.38 +0.3% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $210.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024 |
PTC PTC | $188.94 -0.4% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $210.00 | Low | View details for Oppenheimer rating of PTC (NASDAQ:PTC) on 2/1/2024 |
SEIC SEI Investments | $71.90 -0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $73.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 2/1/2024 |
ROP Roper Technologies | $560.84 +0.3% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $580.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 2/1/2024 |
NDAQ Nasdaq | $63.10 +0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $68.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 2/1/2024 |
NXPI NXP Semiconductors | $247.77 +0.9% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $250.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 2/1/2024 |
MA Mastercard | $481.57 +0.8% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $510.00 | Low | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 2/1/2024 |
BSX Boston Scientific | $68.49 -0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $58.00 -> $68.00 | Low | View details for Oppenheimer rating of Boston Scientific (NYSE:BSX) on 2/1/2024 |
APTV Aptiv | $79.65 +1.3% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $149.00 -> $148.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 2/1/2024 |
AMGN Amgen | $284.32 -0.7% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $350.00 | Low | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 2/1/2024 |
ROK Rockwell Automation | $291.33 +0.0% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $324.00 -> $300.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 2/1/2024 |
BIIB Biogen | $215.63 -0.3% | 1/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $295.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 1/30/2024 |
C Citigroup | $63.24 +0.8% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $95.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 1/30/2024 |
GS The Goldman Sachs Group | $417.69 +0.6% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $491.00 -> $506.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 1/30/2024 |
JPM JPMorgan Chase & Co. | $200.30 +0.4% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $232.00 -> $238.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 1/30/2024 |
MS Morgan Stanley | $94.16 +0.7% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $106.00 -> $109.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 1/30/2024 |
RMD ResMed | $198.03 +0.9% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 1/30/2024 |
USB U.S. Bancorp | $44.70 +1.6% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/30/2024 |
APLS Apellis Pharmaceuticals | $58.78 +0.5% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $79.00 | Low | View details for Oppenheimer rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/30/2024 |
BAC Bank of America | $37.92 +0.3% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $49.00 -> $50.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/30/2024 |
PNST Pinstripes | $3.25 -1.8% | 1/30/2024 | Initiated by | Oppenheimer | - | Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 1/30/2024 |
ST Sensata Technologies | $36.74 +0.9% | 1/30/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $50.00 | Low | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 1/30/2024 |
FIVE Five Below | $181.38 -1.3% | 1/30/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $235.00 -> $200.00 | Low | View details for Oppenheimer rating of Five Below (NASDAQ:FIVE) on 1/30/2024 |
AXP American Express | $227.69 0.0% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $208.00 -> $219.00 | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 1/29/2024 |
CRBP Corbus Pharmaceuticals | $39.24 +10.3% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $51.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 1/29/2024 |
INTU Intuit | $650.00 +0.2% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $610.00 -> $678.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 1/29/2024 |
RXST RxSight | $51.58 +1.8% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $54.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 1/29/2024 |
BFH Bread Financial | $37.24 -1.0% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $52.00 | Low | View details for Oppenheimer rating of Bread Financial (NYSE:BFH) on 1/26/2024 |
COIN Coinbase Global | $265.12 +3.3% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $160.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 1/26/2024 |